Webinar Objectives:
✅ To review current evidence and indications for liver transplantation in neuroendocrine tumours and hepatocellular adenoma.
✅ To discuss patient selection criteria, timing, and outcomes in these rare but challenging indications.
✅ To highlight controversies, ethical considerations, and future directions in expanding transplant eligibility.
Moderators:
Dr. Sudha Kodali (Methodist, USA)
Mr. Abdul Rahman Hakeem (King’s, UK)
Presentations & Speakers:
Liver Transplantation for Neuroendocrine Tumours
Dr. Tahir Shah (Birmingham, UK)
Dr. Shah is a Consultant Liver Transplant Physician at the Queen Elizabeth Hospital, Birmingham, and Lead Clinician for the Neuroendocrine Tumour (NET) and Hepatocellular Cancer (HCC) Services. He established the Midlands’ specialist NET service, leading to its recognition as an ENETS Centre of Excellence. Dr. Shah has pioneered several service development initiatives, including the national liver transplantation programme for unresectable NET liver metastases, a comprehensive service for carcinoid heart disease, and the standardisation of early management pathways for Neuroendocrine Tumours, including lung NETs. His work has significantly advanced multidisciplinary care and national collaboration in complex hepatobiliary oncology.
Liver Transplantation for Hepatocellular Adenomas
Dr. Tara Ghaziani (Stanford, USA)
Dr. Tara Ghaziani is a Clinical Associate Professor of Medicine in Gastroenterology & Hepatology at Stanford, specializing in hepatology and transplant hepatology. Board-certified in Internal Medicine, Gastroenterology, and Transplant Hepatology, she brings expertise in liver cancer and transplant outcomes research. She has authored numerous peer-reviewed publications on hepatocellular carcinoma, liver transplantation, and hepatic function assessment.
Presented by
